Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 21-30 of 34 for

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. Aggressive Malignancy PDX (Avatar) and Cryopreservation Program

    Rochester, MN

  2. Tissue and Blood Registry for Individuals with Liver and Biliary Tumors

    Jacksonville, FL

  3. Immune Response to Antigens

    Jacksonville, FL

  4. University of California Minority Patient-Derived Xenograft (PDX) Development and Trial Center (UCaMP) to Reduce Cancer Health Disparities

    Jacksonville, FL

  5. Short-course Radiation Therapy for Hepatocellular Carcinoma

    Scottsdale/Phoenix, AZ, Rochester, MN

  6. A Study to Evaluate Liver Tumors with Ultrasound Microvessel Imaging and Shear Wave Elastography

    Rochester, MN

  7. Immunomodulation and Patients` Outcomes Following Treatment of Hepatocellular Carcinoma by Radiofrequency Ablation, Microwave Ablation, Trans-Arterial Chemoembolization or Radio-embolization

    Rochester, MN

  8. A Study to Evaluate Personalized Molecular Marker and Immunoprofiling to Transform Hepatocellular Carcinoma Treatment

    Jacksonville, FL

  9. A 5-year Longitudinal Observational Study of the Natural History and Management of Patients With HCC

    Rochester, MN

  10. A Study to Measure the Circulating Tumor Cells in the Blood of the Portal and Hepatic Veins of the Liver During the Transplant Surgery of Patients with Liver Cancer

    Rochester, MN

.

Mayo Clinic Footer